Evidence map›Paper›PMID 40509949›Full record

ArticleJournal of computational chemistry2025

Development of a New AMBER Force Field for Cysteine and Histidine Cadmium-Binding Proteins and Its Validation Through QM/MM MD Simulations.

Matteo Orlandi, Marina Macchiagodena, Piero Procacci, Fabrizio Carta, Claudiu T Supuran, Marco Pagliai

Abstract read
In one paragraph

Article in Journal of computational chemistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Matteo OrlandiDipartimento di Chimica "Ugo Schiff", Università degli Studi di Firenze, Florence, Italy.ORCID https://orcid.org/0009-0005-8033-2666
Marina MacchiagodenaDipartimento di Chimica "Ugo Schiff", Università degli Studi di Firenze, Florence, Italy.ORCID https://orcid.org/0000-0002-3151-718X
Piero ProcacciDipartimento di Chimica "Ugo Schiff", Università degli Studi di Firenze, Florence, Italy.ORCID https://orcid.org/0000-0003-2667-3847
Fabrizio CartaDipartimento di Neuroscienze, Psicologia, Area del Farmaco e Salute del Bambino, Sezione di Scienze Farmaceutiche, Università degli Studi di Firenze, Florence, Italy.ORCID https://orcid.org/0000-0002-1141-6146
Claudiu T SupuranDipartimento di Neuroscienze, Psicologia, Area del Farmaco e Salute del Bambino, Sezione di Scienze Farmaceutiche, Università degli Studi di Firenze, Florence, Italy.ORCID https://orcid.org/0000-0003-4262-0323
Marco PagliaiDipartimento di Chimica "Ugo Schiff", Università degli Studi di Firenze, Florence, Italy.ORCID https://orcid.org/0000-0003-0240-161X

Funding

European Union CUP B83C22002830001ISCRA initiative HP10C13V4SISCRA initiative HP10CV2G9I
6 · The paper itself

Abstract

We developed and validated a novel force field in the context of the AMBER parameterization for the simulation of cadmium(II)-binding proteins. The proposed force field takes into account the polarization effect produced by the central ion on its surroundings. The new polarized atomic charges for cysteine and histidine residues were derived based on the available structures of cadmium-bearing proteins using QM calculations and QM/MM simulations. The developed force field was validated by performing molecular dynamics simulations on several cadmium(II)-binding proteins. Our model preserves the tetra-coordination of the metal site with remarkable stability, yielding mean distances between

Indexed as

CadmiumCysteineHistidineMolecular Dynamics SimulationQuantum TheoryBinding SitesCadmiumCysteineHistidine

Identifiers

PMID40509949
PMCPMC12163698

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.